Abeona Therapeutics (ABEO) Inventory Average (2011 - 2026)
Abeona Therapeutics (ABEO) recorded quarterly Inventory Average of $5.8 million in Q1 2026, up 11.64% quarter-over-quarter from $5.2 million in Q4 2025.
Abeona Therapeutics (ABEO) Inventory Average (2011 - 2026) Analysis & Trends
Abeona Therapeutics' Inventory Average history runs 5 years deep, the most recent figure standing at $5.8 million for Q1 2026.
- In Q1 2026, Inventory Average changed N/A year-over-year to $5.8 million; the TTM figure through Mar 2026 stood at $5.8 million (changed N/A YoY), while the FY2012 annual figure was $172500.0, changed N/A from the prior year.
- Inventory Average was $5.8 million for Q1 2026 at Abeona Therapeutics, up from $5.2 million in the prior quarter.
- In the past five years, Inventory Average ranged from a high of $5.8 million in Q1 2026 to a low of $3.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | - |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 30.59 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | - |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.73 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | Abeona Therapeutics | 309.15 Mn | 140.88 Mn | 6.02 Mn | 5.77 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 5.77 Mn |
| Dec 31, 2025 | 5.17 Mn |
| Sep 30, 2025 | 3.77 Mn |
| Mar 31, 2013 | 172,000.00 |
| Dec 31, 2012 | 215,000.00 |
| Sep 30, 2012 | 258,500.00 |
| Jun 30, 2012 | 189,000.00 |
| Mar 31, 2012 | 124,000.00 |
| Dec 31, 2011 | 171,500.00 |